Background: C-reactive protein (CRP) is used to assist the diagnosis and monitoring of newborn infection. Little is known about CRP activity after birth in the absence of infection. Objective: The aim of this work was to describe postnatal CRP responses in the first days of life in asymptomatic infants with a negative blood culture. Methods: Data were collected from infants who had a blood culture taken at <72 h of age in a UK maternity hospital. All CRP values and their time from birth were recorded. Infants with signs of infection, positive blood culture, or major congenital anomalies were excluded. Infants were analysed by gestation (greater or less than 37 weeks). Normalised CRP curves were generated by linear interpolation and centile curves were derived. Comparisons of median CRP values between groups were made by Mann-Whitney U test at 24, 36, and 48 h. Results: During the study period a total of 219 babies were screened. After exclusions, 73 infants (58 term, 15 preterm) were analysed. In asymptomatic term neonates the CRP (mg/L) peaked at 9.4 after 34.6 h. In preterm babies the CRP peak was 1.75 at 43 h. The median (IQR) values were higher in the term group at 24 and 36 h: 2.5 (1–10.5) versus 0 (0–2.2; p = 0.02) and 3 (0–8.6) versus 0 (0–2.8; p = 0.031). Conclusions: A CRP rise was demonstrated in term and preterm infants without evidence of infection. This rise was greatest in term infants. CRP values must be interpreted in the context of an infant’s clinical condition and not used alone to guide clinical decision making.

1.
Puopolo
K
,
Benitz
E
,
Zaoutis
E
.
AAP COMMITTEE ON FETUS AND NEWBORN, AAP COMMITTEE ON INFECTIOUS DISEASES. Management of neonates born at ≥ 35 0/7 weeks’ gestation with suspected or proven early-onset bacterial sepsis
.
Pediatrics
.
2018
;
142
(
6
):
e20182894
.
[PubMed]
0031-4005
2.
Heath
P
,
O’Sullivan
C
. Group B Streptococcal disease in infants [{LT}] 90 days of age. BPSU Annual Report 2015-16
3.
Stoll
BJ
,
Hansen
N
,
Fanaroff
AA
,
Wright
LL
,
Carlo
WA
,
Ehrenkranz
RA
, et al.
Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants
.
N Engl J Med
.
2002
Jul
;
347
(
4
):
240
7
.
[PubMed]
1533-4406
4.
NICE clinical guideline 149. Neonatal infection (early onset): antibiotics for prevention and treatment.
2012
.
5.
Ishibashi
M
,
Takemura
Y
,
Ishida
H
,
Watanabe
K
,
Kawai
T
.
C-reactive protein kinetics in newborns: application of a high-sensitivity analytic method in its determination
.
Clin Chem
.
2002
Jul
;
48
(
7
):
1103
6
.
[PubMed]
0009-9147
6.
Gutteberg
TJ
,
Askvik
K
,
Jørgensen
T
.
Serum lactoferrin and C-reactive protein in mother and newborn after preterm rupture of membranes
.
Acta Obstet Gynecol Scand
.
1986
;
65
(
3
):
203
5
.
[PubMed]
0001-6349
7.
Chiesa
C
,
Signore
F
,
Assumma
M
,
Buffone
E
,
Tramontozzi
P
,
Osborn
JF
, et al.
Serial measurements of C-reactive protein and interleukin-6 in the immediate postnatal period: reference intervals and analysis of maternal and perinatal confounders
.
Clin Chem
.
2001
Jun
;
47
(
6
):
1016
22
.
[PubMed]
0009-9147
8.
Ainbender
E
,
Cabatu
EE
,
Guzman
DM
,
Sweet
AY
.
Serum C-reactive protein and problems of newborn infants
.
J Pediatr
.
1982
Sep
;
101
(
3
):
438
40
.
[PubMed]
0022-3476
9.
Forest
JC
,
Larivière
F
,
Dolcé
P
,
Masson
M
,
Nadeau
L
.
C-reactive protein as biochemical indicator of bacterial infection in neonates
.
Clin Biochem
.
1986
Jun
;
19
(
3
):
192
4
.
[PubMed]
0009-9120
10.
Chakkarapani
E
,
Davis
J
,
Thoresen
M
.
Therapeutic hypothermia delays the C-reactive protein response and suppresses white blood cell and platelet count in infants with neonatal encephalopathy
.
Arch Dis Child Fetal Neonatal Ed
.
2014
Nov
;
99
(
6
):
F458
63
.
[PubMed]
1468-2052
11.
Nielsen
FR
,
Bek
KM
,
Rasmussen
PE
,
Qvist
I
,
Tobiassen
M
.
C-reactive protein during normal pregnancy
.
Eur J Obstet Gynecol Reprod Biol
.
1990
Apr
;
35
(
1
):
23
7
.
[PubMed]
0301-2115
12.
Vigushin
D
,
Pepys
M
,
Hawkins
P
. Metabolic and scintigraphic studies of radioiodinated C-reactive protein in health and disease. J Clin Invest.
1993
(Apr);91(4):1351-1357
13.
Weinhold
B
,
Rüther
U
.
Interleukin-6-dependent and -independent regulation of the human C-reactive protein gene
.
Biochem J
.
1997
Oct
;
327
(
Pt 2
):
425
9
.
[PubMed]
0264-6021
14.
Pepys
MB
,
Hirschfield
GM
.
C-reactive protein: a critical update
.
J Clin Invest
.
2003
Jun
;
111
(
12
):
1805
12
.
[PubMed]
0021-9738
15.
Benitz
WE
,
Han
MY
,
Madan
A
,
Ramachandra
P
.
Serial serum C-reactive protein levels in the diagnosis of neonatal infection
.
Pediatrics
.
1998
Oct
;
102
(
4
):
E41
.
[PubMed]
0031-4005
16.
Pourcyrous
M
,
Bada
HS
,
Korones
SB
,
Baselski
V
,
Wong
SP
.
Significance of serial C-reactive protein responses in neonatal infection and other disorders
.
Pediatrics
.
1993
Sep
;
92
(
3
):
431
5
.
[PubMed]
0031-4005
17.
Perrone
S
,
Lotti
F
,
Longini
M
,
Rossetti
A
,
Bindi
I
,
Bazzini
F
, et al.
C-reactive protein in healthy term newborns during the first 48 hours of life. Arch Dis. Child. Fetal Neonatal Ed.
2018
(Mar);103(2):F163-F166
18.
Gornikiewicz
A
,
Sautner
T
,
Brostjan
C
,
Schmierer
B
,
Függer
R
,
Roth
E
, et al.
Catecholamines up-regulate lipopolysaccharide-induced IL-6 production in human microvascular endothelial cells
.
FASEB J
.
2000
Jun
;
14
(
9
):
1093
100
.
[PubMed]
0892-6638
19.
Doellner
H
,
Arntzen
KJ
,
Haereid
PE
,
Aag
S
,
Austgulen
R
.
Interleukin-6 concentrations in neonates evaluated for sepsis
.
J Pediatr
.
1998
Feb
;
132
(
2
):
295
9
.
[PubMed]
0022-3476
20.
Vogl
SE
,
Worda
C
,
Egarter
C
,
Bieglmayer
C
,
Szekeres
T
,
Huber
J
, et al.
Mode of delivery is associated with maternal and fetal endocrine stress response
.
BJOG
.
2006
Apr
;
113
(
4
):
441
5
.
[PubMed]
1470-0328
21.
Chiesa
C
,
Natale
F
,
Pascone
R
,
Osborn
JF
,
Pacifico
L
,
Bonci
E
, et al.
C reactive protein and procalcitonin: reference intervals for preterm and term newborns during the early neonatal period
.
Clin Chim Acta
.
2011
May
;
412
(
11-12
):
1053
9
.
[PubMed]
1873-3492
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.